New WTR Biotech Spotlight Podcast! Veru Inc. CEO Mitchell Steiner, MD, FACS joins Tim G. and Do Kim to discuss the next generation of obesity treatments, focusing on lean mass preservation for patients on GLP-1 therapies. ?? Enobosarm Phase 2b data & its impact on muscle retention ?? Why functional clinical benefits matter in obesity treatment ?? Veru’s approach to innovative drug development Listen now to learn more about Veru & enobosarm! ?? Apple: https://lnkd.in/eeVED7vQ Spotify: https://lnkd.in/ezj_gFcE Website: https://lnkd.in/eCCkgqZd #Biotech #ObesityTreatment #GLP1 #MuscleHealth #WTRBiotechSpotlight
Veru Inc.
生物技术研究
Miami，FL 7,866 位关注者
Biopharmaceutical company focused in metabolic diseases and oncology
关于我们
Veru is a biopharmaceutical company focused on developing novel medicines for high-quality weight loss, breast cancer, and viral related ARDS
- 网站
-
https://www.verupharma.com
Veru Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Miami，FL
- 类型
- 上市公司
- 创立
- 2014
地点
-
主要
获取路线
2916 North Miami Ave
US，FL，Miami，33137-3212
Veru Inc.员工
-
Prof. Sergi X. Trilla, MD, MBA
Founder & Chief Executive Partner @ trifermed | ADA Forsyth Adjunct Faculty Memeber
-
Philip Greenberg
Executive Vice President - Deputy General Counsel
-
Kevin Gilbert
Executive Vice President Corporate Development at Veru Inc.
-
Dawn Fitzpatrick
Human Resources, IT & Office Manager at Veru Inc. (Formerly The Female Health Company)
动态
-
A new drug is helping mitigate one of the worst Wegovy side effects: Could it revolutionize obesity medicine? https://lnkd.in/eQgvjCXd
-
Veru is featured in Medscape’s article, “Next Generation Weight Loss Drugs Aim to Save Muscle.” https://lnkd.in/eq8tNf9B
-
New weight loss drugs aim to save muscle https://lnkd.in/gJ8Q_n9G